<DOC>
	<DOCNO>NCT02172560</DOCNO>
	<brief_summary>The objective collect information vital status pulmonary medication use predict exit date patient participate two one-year trial withdraw prematurely . The primary objective ascertain vital status ( dead alive ) patient time interval patient ' withdrawal trial predict exit date ( i.e : 48 week first intake randomised treatment + 30 day ) . The secondary objective collect information class pulmonary medication specify pulmonary intervention use prematurely discontinued patient time predict exit date ( i.e 48 week first intake randomised treatment + 30 day ) date death ( occurred time interval interest , i.e 48 week first intake randomised treatment + 30 day ) .</brief_summary>
	<brief_title>A Collection Vital Status Pulmonary Medication Usage Data Patients With Chronic Obstructive Pulmonary Disease ( COPD ) Who Withdrew Prematurely From Tiotropium Inhalation Solution Delivered Respimat Inhaler</brief_title>
	<detailed_description />
	<mesh_term>Lung Diseases</mesh_term>
	<mesh_term>Lung Diseases , Obstructive</mesh_term>
	<mesh_term>Pulmonary Disease , Chronic Obstructive</mesh_term>
	<mesh_term>Chronic Disease</mesh_term>
	<mesh_term>Tiotropium Bromide</mesh_term>
	<criteria>Patients withdraw prematurely randomise treatment phase study 205.254 205.255 .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>June 2014</verification_date>
</DOC>